Treatment and costs associated with anemic chronic kidney disease patients

Keyphrases

• Active Role 25%
• Anemia 50%
• Anemia of Chronic Kidney Disease 25%
• Anemia Treatment 50%
• Chronic Kidney Disease 25%
• Chronic Kidney Disease Patients 100%
• Cognitive Effects 25%
• Cost Analysis 25%
• Current Therapeutics 25%
• Darbepoetin Alfa 25%
• Dialysis 25%
• Early Detection 25%
• Early Treatment 25%
• Epoetin Alfa 25%
• Erythropoiesis-stimulating Agents 25%
• Erythropoietin 25%
• Healthcare Expenditure 25%
• Healthcare Professionals 25%
• Hemoglobin 25%
• Iron Availability 25%
• Iron Storage 25%
• Literature Search 25%
• MEDLINE 25%
• Ovid 25%
• Physical Effects 25%
• Potential Side Effects 25%
• Therapeutic Potential 25%
• Treatment Options 50%

Nursing and Health Professions

• Anemia 80%
• Antianemic Agent 20%
• Chronic Kidney Failure 100%
• Cost Benefit Analysis 20%
• Drug Therapy 20%
• Erythropoietin 20%
• Health Care Cost 20%
• Health Care Personnel 20%
• Injury 20%
• Procrit 40%
• Side Effect 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 80%
• Antianemic Agent 20%
• Chronic Kidney Failure 100%
• Erythropoietin 20%
• Injury 20%
• Recombinant Erythropoietin 40%
• Side Effect 20%